Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F Cohen

Showing results (81-90 of 219) with videos related to

Pageof 22
Sort By:
British Journal of Clinical Pharmacology|February 1, 1993
CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteersA L van Steveninck, M S Pieters, H C Schoemaker, et al.
Journal of the American College of Cardiology|May 1, 1990
Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasminF W Leebeek, C Kluft, E A Knot, et al.
Epilepsy Research|March 1, 1995
The Neurotoxicity Scale: the validity of a patient-based scale, assessing neurotoxicityA P Aldenkamp, G Baker, M S Pieters, et al.
Lancet (London, England)|December 6, 1997
Is there interaction between tramadol and phenprocoumon?J K Boeijinga, E van Meegen, R van den Ende, et al.
British Journal of Clinical Pharmacology|March 18, 2010
Editors' pick 2009A Somogyi, Y K Loke, A Ferro, et al.
Thrombosis and Haemostasis|January 23, 1991
Physical exercise induces enhancement of urokinase-type plasminogen activator (u-PA) levels in plasmaG Dooijewaard, A de Boer, P N Turion, et al.
British Journal of Clinical Pharmacology|July 21, 2010
Clinical pharmacology: a declaration of intentA Somogyi, Y K Loke, A Ferro, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 21, 2004
[Integration of training in pharmacology and pharmacotherapy in the medical curriculum in Leiden, the Netherlands]E A Dubois, K L Franson, J M van Gerven, et al.
British Journal of Clinical Pharmacology|January 10, 2009
Looking back: editors' pick of 2008Y K Loke, A Somogyi, L D Lewis, et al.
Journal of Psychopharmacology (Oxford, England)|July 23, 2003
REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteersB Rijnbeek, S J de Visser, K L Franson, et al.
Pageof 22

Showing results (81-90 of 219) with videos related to

Sort By:
Pageof 22
British Journal of Clinical Pharmacology|February 1, 1993
CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteersA L van Steveninck, M S Pieters, H C Schoemaker, et al.
Journal of the American College of Cardiology|May 1, 1990
Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasminF W Leebeek, C Kluft, E A Knot, et al.
Epilepsy Research|March 1, 1995
The Neurotoxicity Scale: the validity of a patient-based scale, assessing neurotoxicityA P Aldenkamp, G Baker, M S Pieters, et al.
Lancet (London, England)|December 6, 1997
Is there interaction between tramadol and phenprocoumon?J K Boeijinga, E van Meegen, R van den Ende, et al.
British Journal of Clinical Pharmacology|March 18, 2010
Editors' pick 2009A Somogyi, Y K Loke, A Ferro, et al.
Thrombosis and Haemostasis|January 23, 1991
Physical exercise induces enhancement of urokinase-type plasminogen activator (u-PA) levels in plasmaG Dooijewaard, A de Boer, P N Turion, et al.
British Journal of Clinical Pharmacology|July 21, 2010
Clinical pharmacology: a declaration of intentA Somogyi, Y K Loke, A Ferro, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 21, 2004
[Integration of training in pharmacology and pharmacotherapy in the medical curriculum in Leiden, the Netherlands]E A Dubois, K L Franson, J M van Gerven, et al.
British Journal of Clinical Pharmacology|January 10, 2009
Looking back: editors' pick of 2008Y K Loke, A Somogyi, L D Lewis, et al.
Journal of Psychopharmacology (Oxford, England)|July 23, 2003
REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteersB Rijnbeek, S J de Visser, K L Franson, et al.
Pageof 22